p27(Kip1) and cyclin E expression and breast cancer survival after treatment with adjuvant chemotherapy
about
Multiplexed assessment of the Southwest Oncology Group-directed Intergroup Breast Cancer Trial S9313 by AQUA shows that both high and low levels of HER2 are associated with poor outcomep27: a barometer of signaling deregulation and potential predictor of response to targeted therapies.Cyclin E amplification/overexpression is a mechanism of trastuzumab resistance in HER2+ breast cancer patients.Cancer and Leukemia Group B Pathology Committee guidelines for tissue microarray construction representing multicenter prospective clinical trial tissuesLoss of p27KIP1 expression in fully-staged node-negative breast cancer: association with lack of hormone receptors in T1a/b, but not T1c infiltrative ductal carcinoma.Tissue microarrays in clinical oncologyGene expression profile analysis of t1 and t2 breast cancer reveals different activation pathwaysLoss of nuclear localized and tyrosine phosphorylated Stat5 in breast cancer predicts poor clinical outcome and increased risk of antiestrogen therapy failure.Cytoplasmic Cyclin E and Phospho-Cyclin-Dependent Kinase 2 Are Biomarkers of Aggressive Breast CancerSilencing CDK4 radiosensitizes breast cancer cells by promoting apoptosis.Endocrine dysfunction in p27Kip1 deficient mice and susceptibility to Wnt-1 driven breast cancerp27(Kip1) as a prognostic factor in breast cancer: a systematic review and meta-analysisOutcome of patients with early-stage breast cancer treated with doxorubicin-based adjuvant chemotherapy as a function of HER2 and TOP2A statusCyclin-dependent kinase inhibitor p27 as a prognostic biomarker and potential cancer therapeutic target.Targeting p27Kip1 protein: its relevance in the therapy of human cancer.Protein expression patterns of cell cycle regulators in operable breast cancer.Synthesis, Characterization and Anti-Cancer Activity of Hydrazide Derivatives Incorporating a Quinoline Moiety.Association of cytoplasmic p27 expression with an unfavorable response to cisplatin-based chemotherapy and poor outcomes in non-small cell lung cancer.Cell cycle dysregulation influences survival in high risk breast cancer patients.Prognostic value of cyclin E expression in breast cancer: a meta-analysis.Cytoplasmic Cyclin E Predicts Recurrence in Patients with Breast Cancer.Cyclin E1 is a strong prognostic marker for death from lymph node negative breast cancer. A population-based case-control study.Cyclin D1, p16(INK) (4A) and p27(Kip1) in pancreatic adenocarcinoma: assessing prognostic implications through quantitative image analysis.Role of p27Kip1 as a transcriptional regulator.
P2860
Q33745113-D93F768A-9612-4D99-9188-F5F739A49091Q34472383-4D7160A6-80C1-4FDD-8E2E-8C67FAC2E1F4Q34621219-F975350A-AC59-4CD3-BE6B-B945B2B2DEC4Q35023423-422AB938-78EE-493B-91A4-E461379A43B3Q35919052-B197528B-18DD-4F4C-9FA7-0C28C4060C8BQ36537565-C85D939A-9638-416C-91B6-3F27E9A6B410Q36702209-3C7C0A95-412C-43F0-80FE-C5DAA1E095F7Q36910437-36681761-360D-484C-87C1-9F558C20683CQ37057171-1AA9F890-973F-497D-BBCA-B550F50F8AE3Q37071327-5021B1C4-40C7-43DA-8D8F-4542E38B1AA4Q37214188-D798BE9A-45DC-425B-B3EF-3353C73B30B0Q37295292-13A122CB-09B4-45BC-BB72-529968A3F43CQ37324977-65044260-0134-4E8E-9C14-923B8827C5B0Q37818287-EC5965E8-A1A7-46E2-BE5E-F44D43C33845Q37847584-81816519-A791-4DC5-8DF5-6C36CA5BED73Q38630291-AA8C6DA1-845A-4AC8-93EE-E8D83B4215EDQ38757478-CEC21F24-D54F-493D-8182-D8068B50FF7AQ40414164-A065D185-1F5E-43F2-806C-86B99A72F433Q45225407-64F89F09-8BDF-4683-9F9A-C3CCD5DC8B0AQ45751455-99376954-5E24-4820-8337-A6473B11B4C9Q52955581-5766C18D-0285-4658-8501-AF53FF55DA02Q54314758-96A05D7E-7E03-4FAD-85AD-864EF350B443Q54335649-1EEE2785-3A9C-416D-99C2-D31D96809059Q55074324-1E4B1F27-4EA0-497D-B768-D469EE9029BD
P2860
p27(Kip1) and cyclin E expression and breast cancer survival after treatment with adjuvant chemotherapy
description
2006 nî lūn-bûn
@nan
2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
p27(Kip1) and cyclin E express ...... ent with adjuvant chemotherapy
@ast
p27(Kip1) and cyclin E express ...... ent with adjuvant chemotherapy
@en
p27(Kip1) and cyclin E express ...... ent with adjuvant chemotherapy
@nl
type
label
p27(Kip1) and cyclin E express ...... ent with adjuvant chemotherapy
@ast
p27(Kip1) and cyclin E express ...... ent with adjuvant chemotherapy
@en
p27(Kip1) and cyclin E express ...... ent with adjuvant chemotherapy
@nl
prefLabel
p27(Kip1) and cyclin E express ...... ent with adjuvant chemotherapy
@ast
p27(Kip1) and cyclin E express ...... ent with adjuvant chemotherapy
@en
p27(Kip1) and cyclin E express ...... ent with adjuvant chemotherapy
@nl
P2093
P2860
P356
P1476
p27(Kip1) and cyclin E express ...... ent with adjuvant chemotherapy
@en
P2093
Charles L Shapiro
Charles M Haskell
Daniel F Hayes
Elizabeth Donato
George W Sledge
I-Tien Yeh
James M Roberts
James N Ingle
Kathy S Albain
Ming Gang Lin
P2860
P304
P356
10.1093/JNCI/DJJ467
P407
P577
2006-12-06T00:00:00Z